2008
DOI: 10.1182/blood-2007-11-123844
|View full text |Cite
|
Sign up to set email alerts
|

The human spleen is a major reservoir for long-lived vaccinia virus–specific memory B cells

Abstract: The fact that you can vaccinate a child at 5 years of age and find lymphoid B cells and antibodies specific for this vaccination 70 years later remains an immunologic enigma. It has never been determined how these long-lived memory B cells are maintained and whether they are protected by storage in a special niche. We report that, whereas blood and spleen compart-

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

15
125
0
6

Year Published

2009
2009
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 156 publications
(146 citation statements)
references
References 31 publications
15
125
0
6
Order By: Relevance
“…First, the kinetics, magnitude, and affinity of the TI and TD responses were quite similar. Both responses exhibited a relatively short primary phase versus a prolonged secondary and both maintained the high affinity achieved late in the primary (by week 16), even as the titers began to wane (week [25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44]. This heightened affinity continued into the secondary, with even a slight increase (∼from −log aK 5.9 to 6.2), late in the secondary.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…First, the kinetics, magnitude, and affinity of the TI and TD responses were quite similar. Both responses exhibited a relatively short primary phase versus a prolonged secondary and both maintained the high affinity achieved late in the primary (by week 16), even as the titers began to wane (week [25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44]. This heightened affinity continued into the secondary, with even a slight increase (∼from −log aK 5.9 to 6.2), late in the secondary.…”
Section: Discussionmentioning
confidence: 99%
“…bone marrow versus anterior kidney). One unexplored facet, however, has been the observation that the two distinct cellular arms of mammalian memory, the MBCs and LLPCs, possess distinctly different regionalities, with MBCs centered in peripheral tissues [35][36][37], and LLPCs within the primary lymphoid tissues [29][30][31]. As teleosts possess neither bone marrow nor lymph nodes, the question arises whether comparable regional patterns of dissemination occur in the teleost as well and, if so, whether distinct functional differences are imparted to these different organizational divisions.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Identifying the magnitude and tissue distribution of specific memory T and B cells could be another critical component for assessments of vaccine efficacy with regard to a long-term protective effect [16]. For humoral immunity, it is well known that long-lived plasma cells, but not memory B cells, reside in the bone marrow (BM), while memory B cells are primarily located in the spleen in both mice and humans [17][18][19]. Recent discoveries have demonstrated that the BM is a site where memory CD4 + T cells reside, while the exact location of memory CD8 + T cells is still insufficiently known [20].…”
Section: "Only Very Few Adjuvants Have Been Approved Formentioning
confidence: 99%
“…Despite the therapeutic efficacy of rituximab and methotrexate combinations, the majority of responding patients evidence only a 20% improvement in disease severity (American College of Rheumatology 20) (1)(2)(3)(4). Because rituximab results in near-complete and longlasting B cell depletion, both in the periphery and in secondary lymphoid organs (5,6), efforts to improve outcomes by increasing potency are likely to meet with limited success (4). Furthermore, the discordance between the ability of rituximab to mediate rapid B cell depletion in vivo (7,8) (hours to days) and the delay in maximal treatment effect (weeks to months) implies that downstream effects of B cell loss likely contribute to clinical improvement (9).…”
mentioning
confidence: 99%